vTv Therapeutics Inc. (VTVT)
NASDAQ·Healthcare·Biotechnology
$31.90
+0.11%
Mkt Cap $95.58M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
Implied Upside
+31.7%
Consensus $42.00 vs current $31.90
NASDAQ·Healthcare·Biotechnology
$31.90
+0.11%
Mkt Cap $95.58M
No recent rating data.
Price Target (4 analysts)
$42.00
Range $42.00 – $42.00
+31.7%
Consensus $42.00 vs current $31.90